Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (1001-1010 of 1,142) with videos related to

Pageof 115
Sort By:
Biological Psychiatry|September 26, 2006
The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's diseaseChristine E Marx, William T Trost, Lawrence J Shampine, et al.
Psychiatric Services (Washington, D.C.)|March 17, 2015
Implementing Coordinated Specialty Care for Early Psychosis: The RAISE Connection ProgramLisa B Dixon, Howard H Goldman, Melanie E Bennett, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 29, 2011
Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and explorationRudi Hwang, Arun K Tiwari, Clement C Zai, et al.
The Pharmacogenomics Journal|October 6, 2010
Genome-wide association study of antipsychotic-induced QTc interval prolongationK Aberg, D E Adkins, Y Liu, et al.
Allergy|September 26, 2024
Development and acceptability of a decision-aid for food allergy oral immunotherapy in childrenAikaterini Anagnostou, Elissa M Abrams, Melanie Carver, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2005
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidolRobert B Zipursky, Hongbin Gu, Alan I Green, et al.
The American Journal of Psychiatry|June 4, 2002
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorderRobert M Bilder, Robert S Goldman, Jan Volavka, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 25, 2012
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders studyJean A Frazier, Anthony J Giuliano, Jacqueline L Johnson, et al.
Gut|June 25, 2013
Colorectal cancers soon after colonoscopy: a pooled multicohort analysisDouglas J Robertson, David A Lieberman, Sidney J Winawer, et al.
Pharmacological Research|February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatmentVincenzo De Luca, John B Vincent, Daniel J Müller, et al.
Pageof 115

Showing results (1001-1010 of 1,142) with videos related to

Sort By:
Pageof 115
Biological Psychiatry|September 26, 2006
The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's diseaseChristine E Marx, William T Trost, Lawrence J Shampine, et al.
Psychiatric Services (Washington, D.C.)|March 17, 2015
Implementing Coordinated Specialty Care for Early Psychosis: The RAISE Connection ProgramLisa B Dixon, Howard H Goldman, Melanie E Bennett, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 29, 2011
Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and explorationRudi Hwang, Arun K Tiwari, Clement C Zai, et al.
The Pharmacogenomics Journal|October 6, 2010
Genome-wide association study of antipsychotic-induced QTc interval prolongationK Aberg, D E Adkins, Y Liu, et al.
Allergy|September 26, 2024
Development and acceptability of a decision-aid for food allergy oral immunotherapy in childrenAikaterini Anagnostou, Elissa M Abrams, Melanie Carver, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2005
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidolRobert B Zipursky, Hongbin Gu, Alan I Green, et al.
The American Journal of Psychiatry|June 4, 2002
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorderRobert M Bilder, Robert S Goldman, Jan Volavka, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 25, 2012
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders studyJean A Frazier, Anthony J Giuliano, Jacqueline L Johnson, et al.
Gut|June 25, 2013
Colorectal cancers soon after colonoscopy: a pooled multicohort analysisDouglas J Robertson, David A Lieberman, Sidney J Winawer, et al.
Pharmacological Research|February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatmentVincenzo De Luca, John B Vincent, Daniel J Müller, et al.
Pageof 115